InvestLog
SGMO Sangamo Therapeutics, Inc. logo

SGMO Sangamo Therapeutics, Inc.

Healthcare
$0.19+7.49%ClosedMarket Cap: $76.7M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

5

Dispositions

2

Buy/Sell Ratio

2.50

Net Shares

+4,134,231

Shares Acquired

4,550,000

Shares Disposed

415,769

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 23Dubois-Stringfellow Nathalieofficer: SVP-CHIEF DEVELOPMENT OFFICERSell345,942$0.26332,769
Thu Apr 23Davis Gregory Dofficer: Head of Research & TechnologySell69,827$0.25115,284
Fri Apr 03Willoughby Scott B.officer: SVP, CHIEF LEGAL OFFICER, SECYSell800,000$0.26800,000
Fri Apr 03Macrae Sandydirector, officer: PRESIDENT, CEO AND DIRECTORSell2,500,000$0.262,500,000
Fri Apr 03Jain Nikunjofficer: Principal Accounting OfficerSell225,000$0.26225,000
Fri Apr 03Dubois-Stringfellow Nathalieofficer: SVP-CHIEF DEVELOPMENT OFFICERSell800,000$0.26800,000
Fri Apr 03Davis Gregory Dofficer: Head of Research & TechnologySell225,000$0.26225,000
Thu Feb 26Willoughby Scott B.officer: SVP, CHIEF LEGAL OFFICER, SECYSell12,354$0.47651,406
Thu Feb 26Willoughby Scott B.officer: SVP, CHIEF LEGAL OFFICER, SECYSell1,650$0.47663,760
Thu Feb 26Macrae Sandydirector, officer: PRESIDENT, CEO AND DIRECTORSell33,637$0.471,907,656
Thu Feb 26Macrae Sandydirector, officer: PRESIDENT, CEO AND DIRECTORSell5,291$0.471,941,293
Thu Feb 26Jain Nikunjofficer: Principal Accounting OfficerSell5,119$0.47237,211
Thu Feb 26Jain Nikunjofficer: Principal Accounting OfficerSell666$0.47242,330
Thu Feb 26Dubois-Stringfellow Nathalieofficer: SVP-CHIEF DEVELOPMENT OFFICERSell12,354$0.47678,711
Thu Feb 26Dubois-Stringfellow Nathalieofficer: SVP-CHIEF DEVELOPMENT OFFICERSell2,063$0.47691,065